Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers

Phase 1

Completed

Conditions: Advanced Lung Cancer

Interventions: Drug: Ganetespib (STA-9090) and crizotinib

First Posted Date: 2012-04-18

Last Posted Date: 2020-12-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 13

Registration Number: NCT01579994

Locations: 🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States

and more 2 locations

Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma

Phase 2

Completed

Conditions: Adenoid Cystic Carcinoma

Interventions: Drug: AG-013736 (AXITINIB)

First Posted Date: 2012-03-20

Last Posted Date: 2017-11-28

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 33

Registration Number: NCT01558661

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer

Completed

Conditions: Esophageal Cancer

Interventions: Behavioral: Quality of Life instruments, FACT-E, Symptom Assessment Scale, Brief Pain Inventory and Daily Analgesic Log

First Posted Date: 2012-03-20

Last Posted Date: 2021-08-06

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 257

Registration Number: NCT01558648

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Buparlisib in Metastatic Transitional Cell Carcinoma of the Urothelium

Phase 2

Completed

Conditions: Metastatic Transitional Cell Carcinoma of the Urothelium

Interventions: Drug: Buparlisib

First Posted Date: 2012-03-12

Last Posted Date: 2021-06-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 19

Registration Number: NCT01551030

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center at Mercy Medical Center, Rockville Centre, New York, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸
Memorial Sloan-Kettering at Basking Ridge, Basking Ridge, New Jersey, United States

and more 2 locations

Tissue Oxygenation Are Associated With Anastomotic Leak Rates After an Ivor Lewis Esophagectomy

Completed

Conditions: Esophageal Cancer

Interventions: Device: wireless pulse oximeter (Wipox)

First Posted Date: 2012-03-12

Last Posted Date: 2016-08-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 166

Registration Number: NCT01551433

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Drug: 89Zr-DFO-huJ591

First Posted Date: 2012-03-05

Last Posted Date: 2024-03-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 77

Registration Number: NCT01543659

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Androgen Deprivation Therapy Prior to Prostatectomy for Patients with Intermediate and High Risk Prostate Cancer

Not Applicable

Completed

Conditions: Prostatic Adenocarcinoma
Prostate Cancer

Interventions: Drug: degarelix injection
Drug: androgen deprivation therapy

First Posted Date: 2012-03-01

Last Posted Date: 2024-10-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 41

Registration Number: NCT01542021

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate Cancers

Completed

Conditions: Prostate Cancer
Head and Neck Cancer

Interventions: Other: MRI scanner with sequence

First Posted Date: 2012-02-20

Last Posted Date: 2017-05-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 10

Registration Number: NCT01535898

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Doctor-Patient Communication About Colorectal Cancer Screening

Completed

Conditions: Colorectal Cancer Screening

Interventions: Behavioral: surveys

First Posted Date: 2012-02-17

Last Posted Date: 2020-01-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 76

Registration Number: NCT01534923

Locations: 🇺🇸
Albert Einstein College of Medicine, Bronx, New York, United States
🇺🇸
Hhc, Gun Hill and Tremont, Bronx, New York, United States

MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning

Not Applicable

Completed

Conditions: Brain Cancer

Interventions: Procedure: preoperative fMRI. DTI and DSI with tractography

First Posted Date: 2012-02-16

Last Posted Date: 2023-06-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 145

Registration Number: NCT01534104

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy